BOT 1.18% 42.0¢ botanix pharmaceuticals ltd

1. FDA does mention human factors in the Complete Response...

  1. 2,010 Posts.
    lightbulb Created with Sketch. 1426
    1. FDA does mention human factors in the Complete Response Letter. It is an expectation that it will be completed following the packaging and instruction amendments to ensure those changes are understood by the study group. Resubmission won't be considered without it.
    2. Class 2 includes things other than listed in Class 1 - such as the HF Study. Call me silly, but I'm guessing that is why the EXPERT FDA LAWYER says it is a Class 2 Resubmission. Perhaps he is wrong - 20 years of dealing with FDA cases might do that to you I guess.
    3. The rush to get the resubmission in over Xmas is because the clock is ticking! The 6 months STARTS at the moment of resubmission.
    4. We'll be lucky if we get approval anything before July - fingers crossed. The FDA could just surprise with June '24, but unlikely (or so says the expert FDA lawyer anyway).

    Last edited by Grainofsand: 06/12/23
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
42.0¢
Change
-0.005(1.18%)
Mkt cap ! $761.8M
Open High Low Value Volume
43.0¢ 44.5¢ 42.0¢ $1.621M 3.760M

Buyers (Bids)

No. Vol. Price($)
18 537236 42.0¢
 

Sellers (Offers)

Price($) Vol. No.
42.5¢ 88909 19
View Market Depth
Last trade - 14.34pm 13/09/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.